Delivery Order SPE2DB20D3103-SPE2DB22FP6W0
Award Date
8/30/22
Potential Completion Date
8/31/22
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,557,636 units of Ciprofloxacin HCL 250 mg tablets to the Defense Logistics Agency (DLA). The $1,429.57 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on June 24, 2022, with a completion date of June 27, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,017.84, is a delivery order for the supply of 4,567,074,482 units of Ciprofloxacin HCL 250 mg tablets. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ciprofloxacin HCL 250 mg tablets. The $8,869.16 Firm Fixed Price Delivery Order was awarded on September 20, 2022 by the Defense Logistics Agency (DLA), with a period of performance through September 21, 2022. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award, valued at $2,274.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of 4,565,134,472 units of Ciprofloxacin HCL 500 mg tablets. This is a firm-fixed-price delivery order contract with a period of performance through July 15, 2024. The contract is not designated as a set-aside and was likely awarded through open competition. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery...
This federal contract award is for the delivery of 4,565,420,349 units of ciprofloxacin hydrochloride 250 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,066.41 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award is valued at $2,949.01 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a delivery order. The contract is for the supply of 4,565,860,584 units of Ciprofloxacin HCL 250 MG tablets, a generic antibiotic medication. The contract has a firm fixed price and an ultimate completion date of September 19, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant...
This federal contract award, valued at $4,262.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,565,659,772 units of Ciprofloxacin HCL 250 mg tablets, with an ultimate completion date of September 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of 4,566,110,728 units of Ciprofloxacin HCL 500 mg tablets. The firm-fixed-price, delivery order contract has a ceiling value of $1,682.13 and an ultimate completion date of October 16, 2024. This award is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, has been awarded...
This federal contract award issued by the Defense Logistics Agency (DLA) is a delivery order valued at $4,609.20 and awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,248,373 units of Ciprofloxacin HCL 500 mg tablets and has a completion date of September 21, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of 4,563,827,363 units of Ciprofloxacin HCL 250 MG tablets in 100-count bottles, with a potential value of $1,515.39 and a completion date of March 4, 2024. This delivery order is issued under a $999,999,999.00 indefinite delivery contract (IDC) that...